LENZ Therapeutics Ownership | Who Owns LENZ Therapeutics?
LENZ Therapeutics Ownership Summary
LENZ Therapeutics is owned by 54.26% institutional investors, and 45.74% retail investors. Galileo - Biotech Innovation Fund S USD is the top mutual fund, with 0.51% of its assets in LENZ Therapeutics shares.
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 64 | -4.48% | 31,066,895 | 1.64% | 54 | 1.87% | 30 | -6.25% | 18 | - |
| Sep 30, 2023 | 67 | -4.29% | 30,564,828 | -2.95% | 53 | 1.69% | 32 | -15.79% | 18 | 20.00% |
| Jun 30, 2023 | 70 | 11.11% | 31,494,796 | 5.93% | 56 | 1.99% | 38 | 26.67% | 15 | -11.76% |
| Mar 31, 2023 | 63 | -7.35% | 29,732,465 | 3.28% | 53 | 1.99% | 30 | -9.09% | 17 | 21.43% |
| Dec 31, 2022 | 68 | 4.62% | 28,787,244 | -2.76% | 51 | 1.80% | 33 | - | 14 | -6.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Galileo - Biotech Innovation Fund S USD | 297.94K | 0.51% | - |
| Protea Sectoral Hlthcare Opps P USD Acc | 162.26K | 0.28% | 162.26K |
| NT R2000 Value Index Fund - NL | 72.39K | 0.12% | -10.82K |
| Protea Sectoral Biotech Opps IF USD Acc | 55.00K | 0.09% | 55.00K |
| BlackRock Extended Mkt Composite | 28.33K | 0.05% | 490.00 |
| SSgA U.S. Extended Market Index Class I | 6.10K | 0.01% | - |
| SSgA Russell 2000 Index Strategy | 6.00K | 0.01% | -10.90K |
| NT R3000 Index Fund - NL | 2.90K | 0.01% | -376.00 |
| Blackstone Alternative Multi-Strategy I | 2.00K | 0.00% | -200.00 |
| SSgA U.S. Total Market Index Strategy | 1.76K | 0.00% | -41.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 11, 2022 | AKKARAJU SRINIVAS | Buy | $303.07K | |
| Apr 11, 2022 | Gutry Phil | CHIEF BUSINESS OFFICER | Buy | $20.05K |
| Jan 24, 2022 | Samsara BioCapital, L.P. | - | Buy | $200.10K |
| Jan 21, 2022 | Samsara BioCapital, L.P. | - | Buy | $899.00K |
| Jan 20, 2022 | Samsara BioCapital, L.P. | - | Buy | $384.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2023 Q3 | - | - |
| 2023 Q1 | - | - |
| 2022 Q2 | 2 | - |
| 2022 Q1 | 4 | - |
| 2021 Q4 | 8 | - |
GRPH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools